Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Gas Chromatography Columns

August 26, 2011 7:05 am | Drug Discovery & Development | Product Releases | Comments

The TraceGOLD GC Metal Columns gas chromatography (GC) columns from Thermo Fisher Scientific are metal capillary columns designed for high temperature ranges and can process highly active samples and analytes without incurring any damage. The columns are optimized for use in high-throughput analyses because they are resistant to the column breakdown and bleed caused by repeated sample runs.

TOPICS:

NDA Submission for MoxDuo IR

August 26, 2011 6:58 am | News | Comments

QRxPharma Limited announced submission of its New Drug Application (NDA) clinical data package to the U.S. Food and Drug Administration (FDA) for MoxDuo IR, a Dual Opioid pain therapy comprised of a patented 3:2 fixed ratio combination of morphine and oxycodone.

TOPICS:

Protein May Regulate Fat Metabolism

August 26, 2011 6:55 am | News | Comments

National Institutes of Health (NIH) researchers have found that Parkin, a protein linked with some cases of early-onset Parkinson’s disease, regulates how cells in our bodies take up and process dietary fats.

TOPICS:
Advertisement

Grants Available for Brain Tumor Studies

August 26, 2011 6:51 am | News | Comments

Researchers now have an opportunity to receive grant funds for proof of concept studies and other explorations that push the boundaries of traditional brain tumor diagnostic or treatment approaches.

TOPICS:

Daiichi Sankyo Renames Japan Subsidiary

August 26, 2011 6:47 am | News | Comments

Daiichi Sankyo Company, Limited will reorganize, reinforce, and rename its domestic subsidiary Daiichi Sankyo RD Associe Co. Ltd. As of Oct. 1, the subsidiary will be known as Daiichi Sankyo RD Novare Co. Ltd.

TOPICS:

Light Microscope

August 26, 2011 6:47 am | Product Releases | Comments

With the SR GSD from Leica Microsystems, scientists can achieve resolutions farther below the limit of diffraction than have ever been attained in widefield fluorescence microscopy. The system is capable of resolving details as small as 20 nanometers.

TOPICS:

Rat Collagen

August 26, 2011 6:41 am | Product Releases | Comments

Trevigen has introduced Cultrex Rat Collagen I, Lower Viscosity. Type I collagen is the major structural component of extracellular matrices found in connective tissue and internal organs, but is most prevalent in dermis, tendons, and bone.

TOPICS:

Merck KGaA Appoints Millipore President

August 26, 2011 6:29 am | News | Comments

Merck KGaA announced that Robert Yates will become President of the Merck Millipore division as of September 1, 2011. Executive Board member, Bernd Reckmann, has led the division since Merck’s acquisition of the Millipore Corporation.

TOPICS:
Advertisement

Researchers Screening Plant-based Cancer Therapies

August 26, 2011 6:21 am | News | Comments

Tropical plants may contain the basis of new and effective cancer treatments. Scientists are developing a program for testing plant extracts for the ability to stop ovarian tumors from growing.

TOPICS:

China Clears Rheumatoid Arthritis Drug

August 26, 2011 6:12 am | News | Comments

Chinese drugmaker Simcere Pharmaceutical Group said that its rheumatoid arthritis drug Iremod received marketing approval from China's State Food and Drug Administration.

TOPICS:

FDA Grants Fast Track Status to Alpharadin

August 26, 2011 6:10 am | News | Comments

Algeta ASA announced that Alpharadin has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of castration-resistant prostate cancer in patients with bone metastases.

TOPICS:

Measles Virus Could Target Tumors

August 26, 2011 6:06 am | News | Comments

Canadian researchers have discovered that a tumor cell marker is a receptor for measles virus, suggesting the possible use of measles virus to help fight cancer.

TOPICS:

Discovery Opens Door to Flu Treatments

August 26, 2011 5:55 am | News | Comments

Researchers have reported a discovery that could help scientists develop drugs to fight seasonal influenza epidemics caused by the common influenza B strain.

TOPICS:

Single Vaccine Protects Against Rabies And Ebola

August 26, 2011 5:37 am | News | Comments

Researchers have developed single vaccines to protest against both rabies and the Ebola virus. Successfully tested in mice, these bivalent vaccines have several advantages over other Ebola candidates.

TOPICS:

$200,000 Awarded to University-Industry Teams

August 25, 2011 12:28 pm | News | Comments

The North Carolina Biotechnology Center has issued two $100,000 awards to partnerships between university labs and private companies.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading